Sign in to view content

Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study

David S. Boyer, MD

Video
Published 2021

Related

Episode 4: 3-year Results of the TREX-AMD Trial with Dr. Charles Wykoff
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
Randomized Trial Comparing Pneumatic Retinopexy vs Vitrectomy
Rajeev H. Muni, MD, MSC, FRCS(C), FASRS
Updates from the Field
2017
Types of Strokes Seen in Patients
Sophie Jane Bakri, MD
Updates from the Field
2017

Category: AMD-Non-Neovascular

See more